🇺🇸 FDA
Patent

US 10426767

Methods of treating cancer with farnesyltransferase inhibitors

granted A61KA61K31/4709A61K45/06

Quick answer

US patent 10426767 (Methods of treating cancer with farnesyltransferase inhibitors) held by Kura Oncolofy, Inc. expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Kura Oncolofy, Inc.
Grant date
Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61K, A61K31/4709, A61K45/06